General Information of the Compound
| Compound ID |
CP0133321
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(4-pyridin-2-yl-1,3-thiazol-2-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
AC1N3WC4
AKOS017070888
BDBM50097430
CHEMBL164087
MolPort-004-132-922
N-(4-Pyridin-2-yl-thiazol-2-yl)-benzamide
N-(4-pyridin-2-yl-1,3-thiazol-2-yl)benzamide
N-[4-(2-pyridyl)thiazol-2-yl]benzamide
Oprea1_401409
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H11N3OS
|
||||||||||||||||||
| Molecular Weight |
281.34
|
||||||||||||||||||
| Canonical SMILES |
O=C(Nc1nc(cs1)-c1ccccn1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H11N3OS/c19-14(11-6-2-1-3-7-11)18-15-17-13(10-20-15)12-8-4-5-9-16-12/h1-10H,(H,17,18,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NNBHDRDMPNNEKO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01279, Adenosine receptor A3
Protein ID: PT04390, Lysine-specific demethylase 4B
Clinical Information about the Compound